Childrens National Health Center
Childrens National Health Center
Washington D.C., District of Columbia, United States3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis | LGI1 Autoimmune Encephalitis; NMDAR Autoimmune Encephalitis | Active, not recruiting | Phase 3 | 2026-10-08 | NCT05503264 | |
| Natural History of Sickle Cell Disease | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Respiration Disorders, acute chest syndrome, anemia, cardiovascular disorder, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, hypertensive disorder, inherited hemoglobinopathy, lung disorder, pulmonary hypertension, respiratory system disorder, sickle cell disease, vascular disorder | Recruiting | Not stated | 2026-09-16 | NCT00081523 | |
| A Study of Ocrelizumab in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis | CNS demyelinating autoimmune disease, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder | Active, not recruiting | Phase 2 | 2026-09-14 | NCT04075266 |